Difference between revisions of "Mevalonate pathway with limonene synthesis"
Aliah.hawari (talk | contribs) (→Mevalonate pathway models) |
Aliah.hawari (talk | contribs) (→Mevalonate pathway models) |
||
| Line 4: | Line 4: | ||
== Mevalonate pathway models == | == Mevalonate pathway models == | ||
| + | |||
| + | |||
| + | |||
| + | {| width="80%" | ||
| + | | | ||
[[File:Basic_MVA.png|left|200px|link=]] | [[File:Basic_MVA.png|left|200px|link=]] | ||
| − | [[File:Improved_MVA.png| | + | [[File:Improved_MVA.png|center|300px|link=]] |
| + | |} | ||
Revision as of 15:58, 29 January 2018
The mevalonate (MVA) pathway is one of two independent pathways that is responsible to produce isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) -- the two main precursors to synthesise terpenes. This pathway has seven enzymes to produce IPP and DMAPP, and these compounds are consumed to form geranyl diphosphate (GPP) -- the precursor for the synthesis of monoterpenes such as limonene.
Mevalonate pathway models
  |
